Literature DB >> 33064789

Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.

Bernd Jahrsdörfer1,2, Joris Kroschel3, Carolin Ludwig1, Victor Max Corman4, Tatjana Schwarz4, Sixten Körper1,2, Markus Rojewski1,2, Ramin Lotfi1,2, Christof Weinstock1,2, Christian Drosten4, Erhard Seifried5, Thomas Stamminger6, Hans Jürgen Groß3, Hubert Schrezenmeier1,2.   

Abstract

Highly sensitive and specific platforms for the detection of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are becoming increasingly important for evaluating potential SARS-CoV-2 convalescent plasma donors, studying the spread of SARS-CoV-2 infections, and identifying individuals with seroconversion. This study provides a comparative validation of 4 anti-SARS-CoV-2 platforms. A unique feature of the study is the use of a representative cohort of convalescent patients with coronavirus disease 2019 and a mild to moderate disease course. All platforms showed significant correlations with a SARS-CoV-2 plaque reduction neutralization test, with highest sensitivities for the Euroimmun and the Roche platforms, suggesting their preferential use for screening persons at increased risk of SARS-CoV-2 infections.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CLIA; CMIA; ECLIA; ELISA; SARS-CoV-2; neutralization test; nucleocapsid; spike

Year:  2021        PMID： 33064789      PMCID： PMC7665624          DOI： 10.1093/infdis/jiaa656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  21 in total

1.  B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.

Authors:  Eva Schrezenmeier; Hector Rincon-Arevalo; Ana-Luisa Stefanski; Alexander Potekhin; Henriette Straub-Hohenbleicher; Mira Choi; Friederike Bachmann; Vanessa Pross; Charlotte Hammett; Hubert Schrezenmeier; Carolin Ludwig; Bernd Jahrsdörfer; Andreia Lino; Kai-Uwe Eckardt; Katja Kotsch; Thomas Dörner; Klemens Budde; Arne Sattler; Fabian Halleck
Journal:  J Am Soc Nephrol       Date:  2021-10-19       Impact factor: 10.121

2.  Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination.

Authors:  Simon Ronicke; Bilgin Osmanodja; Klemens Budde; Annika Jens; Charlotte Hammett; Nadine Koch; Bianca Zukunft; Friederike Bachmann; Mira Choi; Ulrike Weber; Bettina Eberspächer; Jörg Hofmann; Fritz Grunow; Michael Mikhailov; Fabian Halleck; Eva Schrezenmeier
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

3.  Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients.

Authors:  Bilgin Osmanodja; Simon Ronicke; Klemens Budde; Annika Jens; Charlotte Hammett; Nadine Koch; Evelyn Seelow; Johannes Waiser; Bianca Zukunft; Friederike Bachmann; Mira Choi; Ulrike Weber; Bettina Eberspächer; Jörg Hofmann; Fritz Grunow; Michael Mikhailov; Lutz Liefeldt; Kai-Uwe Eckardt; Fabian Halleck; Eva Schrezenmeier
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

4.  BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.

Authors:  Bernd Jahrsdörfer; Matthias Proffen; Judith Scholz; Janina Hägele; Carolin Ludwig; Christiane Vieweg; Aline Grempels; Dorit Fabricius; Ramin Lotfi; Sixten Körper; Guido Adler; Hubert Schrezenmeier
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

5.  SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar.

Authors:  Mohamed H Al-Thani; Elmoubasher Farag; Roberto Bertollini; Hamad Eid Al Romaihi; Sami Abdeen; Ashraf Abdelkarim; Faisal Daraan; Ahmed Ibrahim Hashim Elhaj Ismail; Nahid Mostafa; Mohamed Sahl; Jinan Suliman; Elias Tayar; Hasan Ali Kasem; Meynard J A Agsalog; Bassam K Akkarathodiyil; Ayat A Alkhalaf; Mohamed Morhaf M H Alakshar; Abdulsalam Ali A H Al-Qahtani; Monther H A Al-Shedifat; Anas Ansari; Ahmad Ali Ataalla; Sandeep Chougule; Abhilash K K V Gopinathan; Feroz J Poolakundan; Sanjay U Ranbhise; Saed M A Saefan; Mohamed M Thaivalappil; Abubacker S Thoyalil; Inayath M Umar; Zaina Al Kanaani; Abdullatif Al Khal; Einas Al Kuwari; Adeel A Butt; Peter Coyle; Andrew Jeremijenko; Anvar Hassan Kaleeckal; Ali Nizar Latif; Riyazuddin Mohammad Shaik; Hanan F Abdul Rahim; Hadi M Yassine; Gheyath K Nasrallah; Mohamed Ghaith Al Kuwari; Odette Chaghoury; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Open Forum Infect Dis       Date:  2021-05-02       Impact factor: 3.835

6.  Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors:  Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal:  JMIR Public Health Surveill       Date:  2021-04-07

7.  Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.

Authors:  Stephan Schlickeiser; Tatjana Schwarz; Sophie Steiner; Kirsten Wittke; Nabeel Al Besher; Oliver Meyer; Ulrich Kalus; Axel Pruß; Florian Kurth; Thomas Zoller; Martin Witzenrath; Leif Erik Sander; Marcel A Müller; Carmen Scheibenbogen; Hans-Dieter Volk; Christian Drosten; Victor M Corman; Leif G Hanitsch
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

8.  Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.

Authors:  N Ahmad Aziz; Victor M Corman; Antje K C Echterhoff; Marcel A Müller; Anja Richter; Antonio Schmandke; Marie Luisa Schmidt; Thomas H Schmidt; Folgerdiena M de Vries; Christian Drosten; Monique M B Breteler
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

9.  Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.

Authors:  Eva Schrezenmeier; Leon Bergfeld; David Hillus; Joerg-Detlev Lippert; Ulrike Weber; Pinkus Tober-Lau; Irmgard Landgraf; Tatjana Schwarz; Kai Kappert; Ana-Luisa Stefanski; Arne Sattler; Katja Kotsch; Thomas Dörner; Leif Erik Sander; Klemens Budde; Fabian Halleck; Florian Kurth; Victor Max Corman; Mira Choi
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

10.  Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.

Authors:  Sixten Körper; Bernd Jahrsdörfer; Victor M Corman; Jan Pilch; Patrick Wuchter; Rainer Blasczyk; Rebecca Müller; Torsten Tonn; Tamam Bakchoul; Richard Schäfer; David Juhl; Tatjana Schwarz; Nina Gödecke; Thomas Burkhardt; Michael Schmidt; Thomas Appl; Hermann Eichler; Harald Klüter; Christian Drosten; Erhard Seifried; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2021-04-21       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.